ScholarWorks@Korea University College of Medicine: Yu, Cheol Woong

Detailed Information

Yu, Cheol Woong (유철웅)

Anam Hospital (Department of Cardiology, Anam Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

percutaneous coronary intervention:16||drugeluting stent:8||drugeluting stents:8||cardiogenic shock:7||Drugeluting stent:6||Prognosis:6||Percutaneous coronary intervention:6||Peripheral artery disease:6||Cardiogenic shock:5||myocardial infarction:5||acute myocardial infarction:5||Myocardial infarction:5||chronic total occlusion:5||mortality:4||peripheral artery disease:4||extracorporeal membrane oxygenation:4||clinical outcome:4||Acute coronary syndrome:4||bifurcation:4||cilostazol:3||Endovascular treatment:3||Transcatheter aortic valve replacement:3||Endovascular procedures:3||Revascularization:3||Diabetes mellitus:3||atrial fibrillation:3||Coronary artery stenosis:3||Aortic valve stenosis:3||acute coronary syndrome:3||hypertension:3||Chronic total occlusion:3||dyslipidemia:3||coronary bifurcation lesion:2||Bifurcation:2||left main coronary artery:2||allcause mortality:2||amlodipine:2||angioplasty:2||Atherosclerosis:2||major adverse cardiac event:2||diabetes:2||target lesion failure:2||diabetes mellitus:2||Optical coherence tomography:2||metabolic syndrome:2||Instent restenosis:2||obesity:2||outcomes:2||Peripheral arterial disease:2||STEMI:2||Stroke:2||Pitavastatin:2||prognosis:2||extracorporeal cardiopulmonary resuscitation:2||drugeluting stent(s):2||Atrial fibrillation:2||Stent:2||peripheral arterial disease:2||Angioplasty:2||rosuvastatin:2||drugcoated balloon:2||Pioglitazone:2||Pulse wave velocity:2||black raspberry:2||N:2||NSTEMI:2||Femoropopliteal artery disease:1||Ginkgo biloba:1||Glucose control:1||Glycated hemoglobin A:1||Human leukocyte antigenB52 antigen:1||IMPLANTATION:1||Iliac artery:1||Intensive care unit:1||Ischaemic cardiomyopathy:1||Ischemic hindlimb:1||Ischemic postconditioning:1||Korean:1||Koreans:1||Lactate clearance:1||Left atrial appendage occlusion:1||Left main:1||Left main bifurcation:1||Left ventricular systolic dysfunction:1||Longitudinal filling defect:1||Lower extremity:1||Major adverse cardiac event:1||Major adverse event:1||Medina classification:1||Metabolic syndrome:1||MicroRNA:1||MicroRNAs:1||Microfluidic system:1||Mortality:1||Multidetector Computed Tomography:1||Neointima:1||Neovascularization:1||Newonset diabetes:1||Nonischaemic cardiomyopathy:1||PAD:1||Percutaneous coronary artery intervention:1||Percutaneous coronary interventions:1||Platelet inhibitors:1||Pluripotent embryonic stem cell markers:1||Polymers:1||Polyvascular disease:1||Prehypertension:1||Primary percutaneous coronary intervention:1||Pulmonary trunk:1||RANDOMIZEDTRIAL:1||Rectal colonization:1||Registry:1||Renal dysfunction:1||Resolute zotarolimuseluting stent:1||Restenosis:1||Risk factors:1||SAMS:1||SID142:1||ST elevation myocardial infarction:1||STsegmentelevation myocardial infarction:1||Secondgeneration drugeluting stent:1||Sex difference:1||Smooth muscle progenitor cell:1||Statin side effect:1||Stent Deformation:1||Subintimal angioplasty:1||Surveillance:1||TERM OUTCOMES:1||Takayasu arteritis:1||Thrombectomy:1||Ticagrelor:1||Transcatheter aortic valve implantation:1||Treatment outcome:1||True bifurcation lesion:1||Uric acid:1||VRE:1||Vascular endothelial growth factor receptor:1||Vasoactive Inotropic Score:1||Zotarolimus:1||angina:1||angiography:1||anomalous coronary artery:1||anticoagulants:1||antithrombotic agent:1||aortic stenosis:1||atorvastatin:1||augmentation index:1||bifurcation lesion:1||bifurcation lesions:1||body mass index:1||candesartan:1||cardiac injury:1||cardiogenic:1||cardiopulmonary resuscitation:1||central blood pressure:1||chest compression:1||chest injury:1||chronic kidney disease:1||chronic total occlusions:1||clinical outcomes:1||clopidogrel:1||computed tomographic angiography:1||congenital coronary artery anomaly:1||coronary artery aneurysm:1||coronary artery fistula:1||coronary artery spasm:1||coronary bifurcation angioplasty:1||coronary bifurcation stenting:1||coronary computed tomography angiography:1||coronary disease:1||coronary intervention:1||coronary occlusion:1||coronary restenosis:1||critical care:1||critical limb ischemia:1||culprit:1||deferred stenting:1||diabetic:1||diabetic patients:1||dilated cardiomyopathy:1||distal perfusion:1||dobutamine:1||doortocath eter time:1||dopamine:1||drug combination:1||dual antiplatelet therapy:1||elderly:1||electrocardiogram:1||electrocardiography:1||endothelial function:1||endothelial progenitor cells:1||endovascular:1||endovascular treatment:1||everolimus:1||everolimuseluting stent:1||female:1||femoropopliteal artery:1||femoropopliteal artery disease:1||hospital mortality:1||inhospital cardiac arrest:1||incidence:1||infarct size:1||infarct size microvascular obstruction:1||inflammation:1||intraaortic balloon pumping:1||intravascular ultrasound:1||invasive coronary angiography:1||ischemic postconditioning:1||kissing ballooning:1||late luminal loss:1||left:1||left atrial appendage occlusion:1||left main:1||left main coronary artery (LMCA) disease:1||left ventricular ejection fraction:1||left ventricular remodeling:1||lipid:1||lipid core burden index:1||lowdensity lipoprotein cholesterol:1||lowflow time:1||major adverse cardiac events:1||major adverse cerebrocardiovascular events:1||mechanical circulatory support:1||medina 0,0,1 lesion:1||milrinone:1||multiple vessel disease:1||multivessel disease:1||myocardial ischemia:1||nearinfrared spectroscopy:1||neointima:1||nonSTEMI:1||norepinephrine:1||old age:1||optical coherence:1||other technique:1||patency:1||patientoriented composite outcome:1||percutaneous coronary intervention (complex PCI):1||percutaneous transluminal angioplasty:1||physiology:1||pleiotropic effect:1||postprocedural anticoagulation:1||prasugrel:1||predictor:1||prehospital delay:1||probability:1||prophylaxis:1||pulse wave velocity:1||renal insufficiency:1||restenosis:1||revascularization:1||rosuvastatin calcium:1||sTsegment elevation myocardial infarction:1||sarpogrelate:1||secondgeneration drugeluting stent:1||secondary prevention:1||sensitivity and specificity:1||sex:1||shock:1||side branch:1||single coronary artery:1||singlepill combination:1||small vessel coronary disease:1||smoking:1||stable:1||stable angina:1||statin:1||stenosis:1||stent strategy:1||stent technique:1||stent thrombosis:1||stroke:1||surgical aortic valve replacement:1||surgical closure:1||symptom onset:1||symptomtodoor time:1||thrombolysis in myocardial infarction:1||thrombosis:1||thyrotoxicosis:1||ticagrelor:1||tomography:1||transcatheter aortic valve replacement:1||treatment outcome:1||triple antiplatelet therapy:1||triple antithrombotic therapy:1||vasoactive inotropic score:1||vasospastic angina:1||ventricular function:1||warfarin:1||24h blood pressure:1||zotarolimus:1||Adult peripheral blood:1||Angiogenesis:1||Annulus Plane:1||Anplag Tab:1||Aorta:1||Aortic stiffness:1||Aortic valve:1||Arterial stiffness:1||Aspirin:1||Atrial appendage:1||BAREMETAL STENTS:1||Balloon angioplasty:1||Bifurcation lesions:1||Biolimuseluting stent:1||Black raspberry:1||Body mass index:1||Bronchial artery fistula:1||CORONARYARTERYDISEASE:1||CUTTING BALLOON ANGIOPLASTY:1||Calcification:1||Cardiac Image Analysis:1||Carotid intima media thickness:1||Catechin:1||Central blood pressure:1||Chronic coronary total occlusion:1||Chronic kidney disease:1||Circulating stem cells:1||Clinical outcomes:1||Clopidogrel:1||Colitis, ulcerative:1||Combination therapy:1||Computed tomography:1||Convolutional Neural Network:1||Coronary Angiography:1||Coronary artery bypass grafting:1||Coronary artery calcium:1||Coronary artery disease:1||Coronary artery fistula:1||Coronary bifurcation:1||Coronary occlusion:1||Coronary thrombosis:1||Coronary vasospasm:1||Cytokines:1||DPR202:1||Deep Learning TAVR:1||Diabetes:1||Diabetic patients:1||Drug coated balloon:1||Drug eluting stents:1||Drugcoated balloon:1||Drugeluting stents:1||ECMO:1||Elderly:1||Endothelial function:1||Endothelial progenitor cell:1||Endothelialcolony forming cell:1||Endovascular:1||Endovascular procedure:1||Endovascular therapy:1||Epicardial adipose tissue:1||Everolimus:1||Everolimuseluting stent:1||Ezetimibe:1||Factor Xa inhibitors:1||Femoropopliteal artery:1||

STATISTICS: Total View :12,651,292; Today View :5,217

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE